These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 38326577)
1. Lung Mean Dose Prediction in Transarterial Radioembolization (TARE): Superiority of [ Wagemans MEHM; Braat AJAT; van Rooij R; Smits MLJ; Bruijnen RCG; Prince JF; Bol GM; de Jong HWAM; Lam MGEH Cardiovasc Intervent Radiol; 2024 Apr; 47(4):443-450. PubMed ID: 38326577 [TBL] [Abstract][Full Text] [Related]
2. The superior predictive value of Smits MLJ; Dassen MG; Prince JF; Braat AJAT; Beijst C; Bruijnen RCG; de Jong HWAM; Lam MGEH Eur J Nucl Med Mol Imaging; 2020 Apr; 47(4):798-806. PubMed ID: 31399801 [TBL] [Abstract][Full Text] [Related]
3. (⁹⁹m)Tc-MAA overestimates the absorbed dose to the lungs in radioembolization: a quantitative evaluation in patients treated with ¹⁶⁶Ho-microspheres. Elschot M; Nijsen JF; Lam MG; Smits ML; Prince JF; Viergever MA; van den Bosch MA; Zonnenberg BA; de Jong HW Eur J Nucl Med Mol Imaging; 2014 Oct; 41(10):1965-75. PubMed ID: 24819055 [TBL] [Abstract][Full Text] [Related]
4. Safety of a Scout Dose Preceding Hepatic Radioembolization with 166Ho Microspheres. Prince JF; van Rooij R; Bol GH; de Jong HW; van den Bosch MA; Lam MG J Nucl Med; 2015 Jun; 56(6):817-23. PubMed ID: 25931477 [TBL] [Abstract][Full Text] [Related]
5. A simple method for estimating dose delivered to hepatocellular carcinoma after yttrium-90 glass-based radioembolization therapy: preliminary results of a proof of concept study. Kokabi N; Galt JR; Xing M; Camacho JC; Barron BJ; Schuster DM; Kim HS J Vasc Interv Radiol; 2014 Feb; 25(2):277-87. PubMed ID: 24461133 [TBL] [Abstract][Full Text] [Related]
7. High quality imaging and dosimetry for yttrium-90 ( Duan H; Khalaf MH; Ferri V; Baratto L; Srinivas SM; Sze DY; Iagaru A Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2426-2436. PubMed ID: 33443618 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of factors affecting tumor response and survival in patients with primary and metastatic liver cancer treated with microspheres. Demirelli S; Erkilic M; Oner AO; Budak ES; Gunduz S; Ozgur O; Bozcuk H; Sindel HT; Boz A Nucl Med Commun; 2015 Apr; 36(4):340-9. PubMed ID: 25563137 [TBL] [Abstract][Full Text] [Related]
9. Calculation of lung mean dose and quantification of error for Lopez B; Mahvash A; Lam MGEH; Kappadath SC Med Phys; 2019 Sep; 46(9):3929-3940. PubMed ID: 31063600 [TBL] [Abstract][Full Text] [Related]
10. Safety analysis of holmium-166 microsphere scout dose imaging during radioembolisation work-up: A cohort study. Braat AJAT; Prince JF; van Rooij R; Bruijnen RCG; van den Bosch MAAJ; Lam MGEH Eur Radiol; 2018 Mar; 28(3):920-928. PubMed ID: 28786008 [TBL] [Abstract][Full Text] [Related]
11. Comparison of absorbed doses to the tumoral and non-tumoral liver in HCC patients undergoing Noipinit N; Sukprakun C; Siricharoen P; Khamwan K Ann Nucl Med; 2024 Mar; 38(3):210-218. PubMed ID: 38142421 [TBL] [Abstract][Full Text] [Related]
12. Accuracy and Safety of Scout Dose Resin Yttrium-90 Microspheres for Radioembolization Therapy Treatment Planning: A Prospective Single-Arm Clinical Trial. Kokabi N; Webster LA; Elsayed M; Switchenko JM; Chen B; Brandon D; Galt J; Sethi I; Cristescu M; Kappadath SC; Schuster DM J Vasc Interv Radiol; 2022 Dec; 33(12):1578-1587.e5. PubMed ID: 36075560 [TBL] [Abstract][Full Text] [Related]
13. Accuracy and reproducibility of a cone beam CT-based virtual parenchymal perfusion algorithm in the prediction of SPECT/CT anatomical and volumetric results during the planification of radioembolization for HCC. Derbel H; Krichen M; Chalaye J; Saccenti L; Van der Sterren W; Muris AH; Lerman L; Galletto A; Zaarour Y; Luciani A; Kobeiter H; Tacher V Eur Radiol; 2023 May; 33(5):3510-3520. PubMed ID: 36651956 [TBL] [Abstract][Full Text] [Related]
14. SPECT and CT misregistration reduction in [ Lu Z; Chen G; Jiang H; Sun J; Lin KH; Mok GSP Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2319-2330. PubMed ID: 36877236 [TBL] [Abstract][Full Text] [Related]
15. SPECT/CT with 99mTc-MAA in radioembolization with 90Y microspheres in patients with hepatocellular cancer. Hamami ME; Poeppel TD; Müller S; Heusner T; Bockisch A; Hilgard P; Antoch G J Nucl Med; 2009 May; 50(5):688-92. PubMed ID: 19372479 [TBL] [Abstract][Full Text] [Related]
16. Lung Dose Measured on Postradioembolization Stella M; van Rooij R; Lam MGEH; de Jong HWAM; Braat AJAT J Nucl Med; 2022 Jul; 63(7):1075-1080. PubMed ID: 34772794 [TBL] [Abstract][Full Text] [Related]
17. Clinical and Dosimetric Implications of Calculating Lung Shunt Fraction for Hepatic Struycken L; Patel M; Kuo P; Hennemeyer C; Woodhead G; McGregor H AJR Am J Roentgenol; 2022 Apr; 218(4):728-737. PubMed ID: 34704460 [No Abstract] [Full Text] [Related]
18. Prognostic utility of 90Y radioembolization dosimetry based on fusion 99mTc-macroaggregated albumin-99mTc-sulfur colloid SPECT. Lam MG; Goris ML; Iagaru AH; Mittra ES; Louie JD; Sze DY J Nucl Med; 2013 Dec; 54(12):2055-61. PubMed ID: 24144563 [TBL] [Abstract][Full Text] [Related]
19. Comparison of perfused volume segmentation between cone-beam CT and Martin M; Hocquelet A; Debordeaux F; Bordenave L; Blanc JF; Papadopoulos P; Lapuyade B; Trillaud H; Pinaquy JB Diagn Interv Imaging; 2021 Jan; 102(1):45-52. PubMed ID: 33032960 [TBL] [Abstract][Full Text] [Related]
20. 99mTc-macroaggregated albumin poorly predicts the intrahepatic distribution of 90Y resin microspheres in hepatic radioembolization. Wondergem M; Smits ML; Elschot M; de Jong HW; Verkooijen HM; van den Bosch MA; Nijsen JF; Lam MG J Nucl Med; 2013 Aug; 54(8):1294-301. PubMed ID: 23749996 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]